Contact Us
  Search
The Business Research Company Logo
Global Preterm Birth Prevention And Management Market Report 2026
Published :January 2026
Pages :150
Format :PDF
Delivery Time :2-3 Business Days
Why 2-3 days? We update the report with the latest data and news before delivery. Let us know if you need us to expedite.
Report Price :$4,490.00

Preterm Birth Prevention And Management Market Report 2026

Global Outlook – By Product Type (Pharmaceuticals, Medical Devices, Therapies), By Cause-Specific (Multiple Pregnancy, Infection And Chronic Conditions, Structural Abnormalities, Maternal Lifestyle Factors), By Diagnosis Method (Ultrasound Imaging, Biochemical Tests, Physical Examination), By End-User (Hospitals, Clinics, Homecare Settings, Diagnostic Laboratories) - Market Size, Trends, And Global Forecast 2026-2035

Preterm Birth Prevention And Management Market Overview

• Preterm Birth Prevention And Management market size has reached to $2 billion in 2025 • Expected to grow to $2.86 billion in 2030 at a compound annual growth rate (CAGR) of 7.3% • Growth Driver: Growing Awareness Of Maternal And Fetal Health Fueling The Growth Of The Market Due To Increasing Healthcare Access Education And Government Initiatives • Market Trend: Innovative Campaigns Promote Early Intervention For Maternal Health • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.
Research Expert

Book your 30 minutes free consultation with our research experts

What Is Covered Under Preterm Birth Prevention And Management Market?

Preterm birth prevention and management refers to a range of strategies aimed at reducing the risk of babies being born before 37 weeks of gestation and addressing complications associated with early delivery. These strategies involve interventions during pregnancy and after birth to ensure the health and safety of both the mother and baby. The main types of products in preterm birth prevention and management are pharmaceuticals, medical devices, and therapies. Pharmaceuticals refer to medicinal drugs used to prevent or manage preterm labor, including therapies such as progesterone supplements and tocolytics. These are tailored to address specific causes such as multiple pregnancies, infection and chronic conditions, structural abnormalities, and maternal lifestyle factors for various diagnosis methods such as ultrasound imaging, biochemical tests, and physical examination. It includes various end users such as hospitals, clinics, homecare settings, and diagnostic laboratories.
Preterm Birth Prevention And Management Market Global Report 2026 Market Report bar graph

What Is The Preterm Birth Prevention And Management Market Size and Share 2026?

The preterm birth prevention and management market size has grown strongly in recent years. It will grow from $2 billion in 2025 to $2.16 billion in 2026 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to increased awareness of maternal health risks, expansion of prenatal care access, improved diagnostic capabilities, growing use of pharmaceutical interventions, increased monitoring of high-risk pregnancies.

What Is The Preterm Birth Prevention And Management Market Growth Forecast?

The preterm birth prevention and management market size is expected to see strong growth in the next few years. It will grow to $2.86 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to increasing prevalence of high-risk pregnancies, rising investments in maternal healthcare infrastructure, growing adoption of digital prenatal monitoring, expansion of telemedicine in obstetric care, increasing focus on neonatal outcome optimization. Major trends in the forecast period include increasing adoption of early risk screening programs, rising use of advanced prenatal monitoring technologies, growing focus on personalized pregnancy care, expansion of preventive therapeutic interventions, enhanced integration of multidisciplinary care models.

Global Preterm Birth Prevention And Management Market Segmentation

1) By Product Type: Pharmaceuticals, Medical Devices, Therapies 2) By Cause-Specific: Multiple Pregnancy, Infection And Chronic Conditions, Structural Abnormalities, Maternal Lifestyle Factors 3) By Diagnosis Method: Ultrasound Imaging, Biochemical Tests, Physical Examination 4) By End-User: Hospitals, Clinics, Homecare Settings, Diagnostic Laboratories Subsegments: 1) By Pharmaceuticals: Tocolytics, Corticosteroids, Progesterone Therapy, Magnesium Sulfate 2) By Medical Devices: Cervical Cerclage Devices, Fetal Monitoring Devices, Uterine Contraction Monitors 3) By Therapies: Bed Rest Therapy, Nutritional Therapy, Cervical Pessary Therapy

What Is The Driver Of The Preterm Birth Prevention And Management Market?

The growing awareness of maternal and fetal health is expected to propel the growth of the preterm birth prevention and management market going forward. Maternal and fetal health refers to the well-being of pregnant women and their unborn babies, ensuring safe pregnancies and healthy outcomes. Awareness of maternal and fetal health is growing as educational campaigns and awareness programs are actively promoting the importance of prenatal care, proper nutrition, vaccination, and regular screenings to ensure healthier pregnancy outcomes. Preterm birth prevention and management are essential for maternal and fetal health, as they help reduce complications such as respiratory distress and developmental delays in newborns while also lowering maternal health risks associated with premature delivery. For instance, in July 2024, according to the Welsh Government (Llywodraeth Cymru), a UK-based governing body, in 2023, the percentage of pregnant women with a BMI of 30 or higher at their initial assessment increased to 32%, reflecting a 0.8 percentage point rise from the previous year. Therefore, the growing awareness of maternal and fetal health is driving the growth of the preterm birth prevention and management industry.

Key Players In The Global Preterm Birth Prevention And Management Market

Major companies operating in the preterm birth prevention and management market are Philips Healthcare, GE Healthcare Technologies Inc, Hologic Inc, QIAGEN NV, Ferring Pharmaceuticals, AMAG Pharmaceuticals, Natus Medical Incorporated, Sera Prognostics, Progenity Inc, CooperSurgical Inc, Medtronic plc, Abbott Laboratories, Siemens Healthineers AG, Roche Diagnostics International AG, Thermo Fisher Scientific Inc, Danaher Corporation, BD Becton Dickinson And Company, Olympus Corporation, Fujifilm Holdings Corporation, Cook Medical LLC, Karl Storz SE And Co KG, Baxter International Inc

What Are Latest Mergers And Acquisitions In The Preterm Birth Prevention And Management Market?

In February 2024, Novocuff Inc., a US-based medical device company, partnered with Fogarty Innovation (FI) to further its mission of preventing preterm births and improving pregnancy outcomes. This collaboration aims to advance its cervical control device aimed at preventing preterm births, receiving a six-month mentorship through Fogarty's Company Accelerator Program to refine its technology and prepare for a pivotal U.S. multi-center clinical trial in early 2025, with the goal of global commercialization. Fogarty Innovation (FI) is a US-based nonprofit educational incubator dedicated to advancing medical innovation that improves human health.

Regional Outlook

North America was the largest region in the preterm birth prevention and management market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Need data on a specific region in this market?

What Defines the Preterm Birth Prevention And Management Market?

The preterm birth prevention and management market includes revenues earned by entities by providing services such as prenatal screening and risk assessment, maternal health monitoring, pharmaceutical and therapeutic interventions, neonatal intensive care (NICU) services, and postnatal rehabilitation and support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Preterm Birth Prevention And Management Market Report 2026?

The preterm birth prevention and management market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the preterm birth prevention and management industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Preterm Birth Prevention And Management Market Report Forecast Analysis

Report Attribute Details
Market Size Value In 2026$2.16 billion
Revenue Forecast In 2035$2.86 billion
Growth RateCAGR of 7.7% from 2026 to 2035
Base Year For Estimation2025
Actual Estimates/Historical Data2020-2025
Forecast Period2026 - 2030 - 2035
Market RepresentationRevenue in USD Billion and CAGR from 2026 to 2035
Segments CoveredProduct Type, Cause-Specific, Diagnosis Method, End-User
Regional ScopeAsia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country ScopeThe countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies ProfiledPhilips Healthcare, GE Healthcare Technologies Inc, Hologic Inc, QIAGEN NV, Ferring Pharmaceuticals, AMAG Pharmaceuticals, Natus Medical Incorporated, Sera Prognostics, Progenity Inc, CooperSurgical Inc, Medtronic plc, Abbott Laboratories, Siemens Healthineers AG, Roche Diagnostics International AG, Thermo Fisher Scientific Inc, Danaher Corporation, BD Becton Dickinson And Company, Olympus Corporation, Fujifilm Holdings Corporation, Cook Medical LLC, Karl Storz SE And Co KG, Baxter International Inc
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options
Chat with us